Harmony Biosciences Statistics
NASDAQ: HRMYHealth CareBiotechnology: Pharmaceutical PreparationsUSD
39.60+0.26 (+0.66%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Harmony Biosciences by the numbers
Harmony Biosciences has a market capitalization of $2.31 billion based on 58.24M shares outstanding. Its trailing P/E ratio is 12.7, below the 3-company peer median of 13.4, and its forward P/E is 5.7. The stock trades 0.6% below its 50-day average and 14.2% above its 200-day average.
Average daily trading volume is 892.55K shares, or about $35.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
HRMY valuation vs. peer median
| Metric | HRMY | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.31B | $2.27B | +2% |
| P/E (TTM) | 12.7 | 13.4 | -5% |
| Forward P/E | 5.7 | 12.3 | -54% |
| Avg. volume | 892.55K | 860.16K | +4% |
Peer median across 8 companies: NRIX, SLS, PBH, BHC, IRON, HCM, PHVS, AUPH.
Valuation
- Market cap
- $2.31B
- P/E (TTM)
- 12.69
- Forward P/E
- 5.65
- EPS (TTM)
- $3.12
- Shares outstanding
- 58.24M
Price and trading
- Previous close
- 39.34
- Open
- 39.14
- Day range
- 38.68 – 39.89
- 52-week range
- 25.52 – 43.49
- 52-week change
- +49.10%
- Beta
- —
- Volume
- 803.23K
- Average volume
- 892.55K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 2.31B
- Pe
- 12.69
- Forward Pe
- 5.65
- Eps
- 3.12
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 43.49
- Week52 Low
- 25.52
- Avg Volume
- 892.55K
- Shares Outstanding
- 58.24M
- Ma50
- 39.84
- Ma200
- 34.67
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -8.94%
- Pct From52w Low
- 55.17%